Your shopping cart is currently empty

cis-13,16,19-Docosatrienoic acid methyl ester is an ester form of docosatrienoic acid, a rare ω-3 fatty acid. This compound is not easily detectable in the normal phospholipid polyunsaturated fatty acid pool and at a concentration of 5 μM, it inhibits the binding of [3H]-LTB4 to porcine neutrophils. The methyl ester form exhibits greater lipid solubility than the free acid, potentially making it more suitable for certain formulations.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | cis-13,16,19-Docosatrienoic acid methyl ester is an ester form of docosatrienoic acid, a rare ω-3 fatty acid. This compound is not easily detectable in the normal phospholipid polyunsaturated fatty acid pool and at a concentration of 5 μM, it inhibits the binding of [3H]-LTB4 to porcine neutrophils. The methyl ester form exhibits greater lipid solubility than the free acid, potentially making it more suitable for certain formulations. |
| Molecular Weight | 348.56 |
| Formula | C23H40O2 |
| Cas No. | 108698-01-7 |
| Smiles | CC/C=C\C/C=C\C/C=C\CCCCCCCCCCCC(OC)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.